No Data
No Data
CCB International: Maintaining Ali Health's (00241) “Outperform Market” Rating Target Price by 33% to HK$4.2
CCB International cut Ali Health's (00241) revenue forecast for 2024 by 16.4%.
Big Bank Rating | Dahua Jixian: Lowering Ali Health's Target Price to HK$4 to Maintain “Buy” Rating
Dahua Jixian published a report. Alibaba Health's revenue for the 2024 fiscal year is expected to drop 5% year-on-year, adjusted profit will increase by 30% year-on-year, and the revenue and profit targets for fiscal year 2025 are 15% and 70% year-on-year growth, respectively. As business expansion was slower than expected, the bank lowered Ali Health's revenue growth forecast for the 2024 and 2025 fiscal years from 14% and 21% to -5% and 15%, respectively, but with the synergy between steady demand for healthcare products and Ali Mama's marketing business, it remains optimistic about its long-term growth prospects. Dahua Jixian maintains Ali Health's “buy” rating, and the target price was lowered from HK$6 to HK$4
Lyon: Maintaining Ali Health's (00241) “Buy” Rating Target Price Reduced to HK$4.1
The Zhitong Finance App learned that Lyon released a research report stating that the target price for Ali Health (00241) was lowered from HK$5.6 to HK$4.1, maintaining the “buy” rating. The bank expects Alibaba Health to face a higher base effect than expected in the second half of fiscal year 2024. Revenue is expected to fall 19% year on year, and adjusted net profit is expected to drop 12% year on year. It also pointed out that Alibaba Health's business growth should be normalized in February of this year. Revenue and adjusted net profit for fiscal year 2025 are expected to increase by more than 16% and 70% respectively, benefiting from Ali Mama's advertising platform sharing advertising revenue.
Changes in Hong Kong stocks | Alibaba Health (00241) fell more than 4%, institutions say online drug sales are slowing down in the long term or facing challenges
Ali Health (00241) fell by more than 4%. As of press release, it was down 4.23% to HK$2.94, with a turnover of HK$98.481,600.
Dragon (01930) will pay a final dividend of HK$0.00241 per share on July 26
Qilong (01930) announced that the company will pay a final dividend of 0.00 per share on July 26, 2024...
Ali Health (00241.HK) grants a total of 1.93 million restricted share units
Gelonghui March 15 | Ali Health (00241.HK) issued an announcement. On March 15, 2024, the company granted a total of 1.93 million restricted share units to 12 grantees in accordance with the terms of the share award plan. The purpose of granting restricted share units is: (i) to provide skilled and experienced persons with an opportunity to acquire shares in the company in order to absorb them to promote the further development and expansion of the Group; (ii) recognize the contributions of the Group's current employees to the Group's success and development; and/or (iii) comprehensively motivate and encourage employees to remain in the Group to promote future development and expansion.
No Data